Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences
BRIEF-ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences June 25 (Reuters) - ASP Isotopes Inc ASPI.O:
ASP ISOTOPES ANNOUNCES PROPOSED MERGER OF NOBLE AFRICA WITH ENDRA LIFE SCIENCES AND APPROXIMATELY $50 MILLION CONCURRENT PRIVATE PLACEMENT FINANCING
ASP ISOTOPES - COMBINED COMPANY TO OPERATE AS NOBLE AFRICA AND APPLY TO TRADE AS NOBA ON NASDAQ
ASP ISOTOPES - TO OWN ABOUT 89% OF COMBINED COMPANY AFTER MERGER
ASP ISOTOPES - NOBLE AFRICA SECURES $50 MILLION PRIVATE PLACEMENT COMMITMENTS
ASP ISOTOPES - PAUL E. MANN TO SERVE AS CEO, NICK MITCHELL AS COO OF COMBINED COMPANY
ASP ISOTOPES - ENDRA STOCKHOLDERS TO OWN 3%, PRIVATE PLACEMENT INVESTORS TO OWN 7% OF COMBINED COMPANY
ASP ISOTOPES - TO INVEST $20 MILLION AS LEAD INVESTOR IN PRIVATE PLACEMENT
Source text: ID:nGNX55FKDr
Further company coverage: ASPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences